The 2011 Harvard Cambridge Scholars

Four new graduates head back to school—in the other Cambridge

Four members of the class of 2011 have won Harvard Cambridge Scholarships to study at Cambridge University during the 2010-2011 academic year. English concentrator Molly Fitzpatrick, of Winthrop House and River Edge, New Jersey, will be the Lionel de Jersey Scholar at Emmanuel College; social studies concentrator Jacob McNulty, of Dunster House and Short Hills, New Jersey, will be the John Eliot Scholar at Jesus College; chemical and physical biology concentrator James Pelletier, of Adams House and Attleboro, Massachusetts, will be the Governor William Shirley Scholar at Pembroke College; and applied mathematics concentrator Jackson Salovaara, of Pforzheimer House and Bernardsville, New Jersey, will be the Charles Henry Fiske III Scholar at Trinity College.

Related topics

You might also like

A new book explores the Harvard-trained architect’s vision and impact, from Ground Zero to the Smithsonian.

In 2004, a frenzy spread across Harvard Yard in days. Four billion users later, we are only just catching up.

The play Spare Parts is a contemporary fable about the quest to live forever.

Most popular

Lafayette’s Unexpected Gift to George Washington: Pheasants

The two birds will be on display at Harvard this summer.

Harvard Weathers a Year of Turmoil

The federal government has launched unprecedented actions against the University. Here’s a guide.

A former Harvard College writing tutor changes her mind on LLMs.

Explore More From Current Issue

A football player in a white jersey evades a defender in a green uniform on the field.

Despite personnel losses, Crimson captain Xaviah Bascon is upbeat about the 2026 season.

Smiling woman stands beside a large skull in a display cabinet.

From competing in youth gymnastics to studying tetrapods, the Harvard curator has always chased her curiosity.

A glowing bulb shape surrounded by colorful, swirling energy lines against a blue background.

Harvard researchers achieve medical breakthroughs in cancer therapy and infection control.